Condition: Obesity · Sponsor: Centre Hospitalier Departemental Vendee
The aim of the study is to assess impact of omentopexy on de novo gastro-oesophageal reflux disease (GERD) after sleeve gastrectomy. This will be assess 2 years postoperatively. This study is a prospective, multicentric, randomized trial. Five hundred twenty six patients should be included with 263 in each arm. First arm will include patients who have a sleeve gastrectomy. The second arm will include patients who have sleeve gastrectomy with omentopexy. Two years after surgery , it will be collected a CARLSSON score and BAROS score (quality of life). The main objective is to show that omentopexy decreases the rate of de novo GERD after sleeve gastrectomy at 2 years postoperatively without the use of Proton-Pump Inhibitors (PPIs)
This description comes directly from the study's public registry record.
Agnès Dorion · 251446380 · agnes.dorion@chd-vendee.fr
Always discuss trial participation with your own doctor first.
| CH de la Cote Basque | Bayonne, France | Recruiting |
| CHD Vendée | La Roche-sur-Yon, France | Recruiting |
| Centre Hospitalier Emile Roux | Le Puy-en-Velay, France | Recruiting |
| CHU Nantes | Nantes, France | Recruiting |
| Clinique Jules Verne | Nantes, France | Recruiting |
| Centre Hospitalier Régional et Universitaire d'Orléans | Orléans, France | Recruiting |
| Hopital Pontchaillou | Rennes, France | Recruiting |
| Clinique Mutualiste de la Sagesse | Rennes, France | Not Yet Recruiting |
| Clinique Santé Atlantique | Saint-Herblain, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04994665